Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,823 total articles
ServiceTitan's targeted rollout of Max AI features is already tightening margins while preserving 25%+ top-line growth. The stock has repriced after AI fears, creating a setup where accelerating gross margins and steady free cash flow can drive a re-rating. This trade idea lays out an entry at $90.81, a $118 target and a $78 stop, with a long-term …
Covista (CVSA) combines recurring education revenue, solid free cash flow, and manageable leverage. With the stock trading near $131 and fundamentals showing room for margin upside, a disciplined long trade offers asymmetric reward if enrollment and operating efficiency continue to improve.
Nektar trades near $73.50 after a big run; the imminent commercial development of rezpegaldesleukin (REZPEG) and fresh institutional buying create asymmetric upside vs defined downside. This trade plan targets $95 over the next 45 trading days with a strict $64 stop to respect binary clinical and legal risks.
NexGen Energy sits at the front of the next uranium supply wave. Federal approvals and institutional buying have compressed political and permitting risk; construction execution now becomes the primary moat. This trade idea offers a defined entry at $10.35, a stop at $8.90 and a target at $13.50 over a mid-term 45-trading-day horizon, balancing ups…
ABN AMRO trades around 1.25x book value, offers a constructive mix of earnings resilience and capital flexibility, and looks like a buy for active investors prepared to hold through a couple of quarters of macro noise. We lay out an actionable entry, stop and price target with a 45-trading-day horizon and clear risk controls.
Vicor sits at the junction of two tailwinds: high-density power conversion for AI accelerators and a ramping backlog tied to hyperscalers. Revenue growth and gross margins are strong, but the stock trades at premium multiples. This trade idea offers a measured long exposure with a concrete entry, stop and target tied to capacity execution and topli…
Adicet Bio (ACET) offers a low-cap, high-volatility way to play off-the-shelf gamma delta T-cell therapies. At a market cap ~ $77M and a current price of $8.20, the stock looks inexpensive on book value and enterprise value, but the path to upside hinges on clinical readouts and capital markets activity. This trade lays out an actionable long with …
Salesforce's unprecedented $27 billion buyback has reset the risk/reward profile. The company still generates strong free cash flow, the technical setup is constructive, and short interest has compressed. This trade targets a rebound toward prior resistance, while respecting leverage and execution risk.
ATI has been a standout performer as aerospace and defense activity recovers, but the stock now trades at a premium (P/E ~65, P/B ~16.7) with stretched momentum indicators. I am downgrading my stance and proposing a mid-term short trade: entry $227.80, target $196.00, stop $246.00 — horizon 45 trading days. The thesis rests on valuation mean revers…
Sandisk's investor day introduced aggressive long-term margin and growth targets and disclosed substantial contract visibility. Those details materially change the risk/reward: I upgrade to a tactical long. This trade idea lays out entry, stop, targets, and the key catalysts and risks that will determine whether the upgraded view holds.
Banner Corp (BANR) looks positioned for an accretive acquisition play: low leverage, strong free cash flow ($308.9M), and a 2.72% yield with a fresh dividend payable on 08/14/2026. We outline a mid-term (45 trading days) trade plan to capture potential upside on deal optionality and continued multiple expansion.
Sandisk's investor day (08/14/2026) laid out ambitious targets - mid-to-high-teens revenue growth, ~80% gross margins, ~75% operating margins and ~50% free cash flow margins through fiscal 2030. The market is clearly skeptical: the stock trades with a $250.0B market cap and conservative multiples that embed a much lower long-term margin profile. Th…
Sentiment around hyperscaler AI capex has turned frothy and then fearful; that swing has created a buying opportunity in Meta (META). Fundamentals show strong cash generation ($41B free cash flow), reasonable multiples (PE ~22), and a diversified revenue base that cushions Reality Labs' volatility. This trade targets $660 with a $560 stop over a mi…
Mobileye trades at $8.95 and a market cap near $7.6B while generating meaningful free cash flow and retaining a dominant ADAS position across automakers. The stock discounts the company's robotaxi and autonomy upside. This trade idea lays out an entry at $8.95, a stop at $7.50 and a target of $14.00 over a 180-trading-day horizon, with catalysts an…
Grupo Aeroportuario del Sureste (ASR) reported a quiet Q2 market reaction, but its airport portfolio — anchored by Cancun — has a clear path to revenue and earnings acceleration as tourism and concession recovery reassert themselves into 2027. Valuation looks reasonable at a $7.9B market cap and a P/E near 15. This is a tactical long with a 180-tra…
FutureFuel has been repositioning away from low-margin biodiesel and toward specialty chemicals while quietly building optionality via a uranium portfolio acquisition. The stock is trading near $5.63 with a market cap around $295M, an enterprise value of $214.8M and a net-cash-like balance sheet. For traders willing to accept mid-term operational r…
Gogo is a small-cap satcom play with a heavy operational backlog of pre-provisioned aircraft and several recent STC wins. At ~$2.79/share and a market cap near $379M, the stock looks mispriced for a successful roll-out of antenna installations and new 5G ATG trials. This trade targets a mid-term replay of investor attention once installation approv…
SentinelOne ($23.22) is trading near a fresh 52-week high after a rocky earnings reaction. Fundamentals show continued ARR and revenue growth, improving margins, and positive free cash flow — but valuation is full. This trade idea lays out an actionable long with entry at $23.22, stop at $18.00 and a target of $36.00 over a 180-day horizon, backed …
Nebius is consolidating its position as a neocloud leader: rapidly expanding GPU capacity, landmark customer deals, and a move toward asset-light expansion. The stock is volatile and richly valued, but recent results and contract wins give a measurable growth runway. This trade idea lays out an actionable long with entry at $268.00, a cautious stop…
Corporacion Inmobiliaria Vesta (VTMX) is trading at roughly $34 with a market cap of about $3.0B, a PE of 7.4 and PB near 1.0. Recent operational momentum - including 14.4% y/y rental income growth and the elimination of secured debt - plus a conservative valuation make this a long-term buy. Trade plan: entry $34.00, target $40.00, stop $31.00 over…
Central Garden & Pet (CENT) is trading at roughly a 12% free cash flow yield with a P/FCF near 8 and a market cap under $2.8B. Management is shedding low-margin distribution while keeping a minority stake, which should lift consolidated margins and clarify valuation. This trade targets a rerating to a more normal consumer multiple while keeping a t…
Winnebago trades cheaply relative to its cash generation and pays a sizable 4.3% yield. I view a disciplined long position here as a tactical way to collect yield and ride a recovery, but this is not a smooth road - declining unit volumes and a tougher consumer backdrop will create headline risk.
Boston Scientific (BSX) has been pummeled since its 52-week high but still sits on solid fundamentals: $80.6B market cap, $3.62B free cash flow and a diversified device franchise exposed to multiple secular growth markets. Management's recent insider purchase and a $500M restructuring initiative point to near-term stabilization. This trade idea out…
Check Point reported improving subscription growth and still generates healthy free cash flow. The stock has fallen from last year's highs, leaving a ~$13.5B market cap and a trailing earnings multiple that implies limited downside if execution normalizes. We upgrade to Buy and recommend a staged long with clear stop and two time-based targets.
Domino's (DPZ) has been punished for slowing comp trends and a CEO transition, but the business still generates meaningful free cash flow, carries a net-cash balance sheet, and trades at a valuation that offers a favorable risk-reward for a mid-term rebound. This trade idea outlines a concrete entry, stop, and target with catalysts and risks framed…
